Professor of Psychiatry Director of the Program for Positive Aging
Psychiatry
Dr. Helen C. Kales, MD
|
|
Give Review
Helen Kales practices Psychiatry. He attended University of Rochester School of Medicine and Dentistry. He received 1 awards: "CMS Meaningful Use Stage 1 Certification". Helen C. Kales, MD is a published doctor. He has 44 papers published. The most current publication "Association of Antipsychotic Use With Mortality Risk in Patients With Parkinson Disease." He accepts Medicare payments and is listed with Medicare.gov.
Publications
- Estimating Mortality Associated With Antipsychotics and Other Psychotropics-Reply.
- Associations between depression and all-cause and cause-specific risk of death: A retrospective cohort study in the Veterans Health Administration.
- Treatment changes among older patients with dementia treated with antipsychotics.
- Antipsychotics, Other Psychotropics, and the Risk of Death in Patients With Dementia: Number Needed to Harm.
- Differential prefrontal and subcortical circuitry engagement during encoding of semantically related words in patients with late-life depression.
- Management of Neuropsychiatric Symptoms of Dementia in Clinical Settings: Recommendations from a Multidisciplinary Expert Panel.
- The association between race and gender, treatment attitudes, and antidepressant treatment adherence.
- The role of the occupational therapist in the management of neuropsychiatric symptoms of dementia in clinical settings.
- Mindfulness-Based Cognitive Therapy With Older Adults: An Exploratory Study.
- Evaluation of the FDA warning against prescribing citalopram at doses exceeding 40 mg.
- Trends and Predictors of Quality of Care in VA Nursing Homes Related to Serious Mental Illness.
- Racial Differences in Adherence to Antidepressant Treatment in Later Life.
- Depression and cognitive impairment in older adults.
- Mortality risk with the use of atypical antipsychotics in later-life bipolar Disorder.
- Risk of mortality among individual antipsychotics in patients with dementia.
- Predictors of suicide in patients with dementia.
- After the black box warning: predictors of psychotropic treatment choices for older patients with dementia.
- Patterns and trends in antipsychotic prescribing for Parkinson disease Psychosis.
- Trends in antipsychotic use in dementia 1999-2007.
- Later-life depression and heart failure.
- Improving antidepressant adherence and depression outcomes in primary care: the treatment initiation and participation (TIP) program.
- Who receives outpatient monitoring during high-risk depression treatment periods?
- Comorbidity of cognitive and mood Disorders: furthering the understanding of heterogeneity.
- The effect of depression and cognitive impairment on enrollment in Medicare Part D.
- Does consideration of Medicare use affect VA evaluations of treatment for new episodes of depression?
- Increases in Medicare prescription Drug plan costs attributable to psychotropic medications.
- Criminal background checks for psychiatry? Michigan's Mental health exceptionalism.
- Mortality risk in patients with dementia treated with antipsychotics versus other psychiatric medications.
- Antidepressant treatment of veterans with Parkinson's disease and depression: analysis of a national sample.
- Race and depression: does race affect the diagnosis and treatment of late-life depression?
- International medical graduates and the diagnosis and treatment of late-life depression.
- Diagnosis and management of bipolar Disorder with comorbid anxiety in the elderly.
- Race, gender, and psychiatrists' diagnosis and treatment of Major depression among elderly patients.
- Rates of clinical depression diagnosis, functional impairment, and nursing home placement in coexisting dementia and depression.
- Effect of race and sex on primary care physicians' diagnosis and treatment of late-life depression.
- New-onset bipolar Disorder in later life.
- Cerebrovascular disease and late-life depression.
- Disruptive behaviors in Veterans Affairs nursing home residents: how different are residents with serious Mental illness?
- Age-related modifiers of clinical presentation and health service use among veterans with bipolar Disorder.
- Benzodiazepine use among depressed patients treated in Mental health settings.
- Assessment and management of behavioral and psychological symptoms of dementia.
- Association of Antipsychotic Use With Mortality Risk in Patients With Parkinson Disease.
- Augmenting Ongoing Depression Care With a Mutual Peer Support Intervention Versus Self-Help Materials Alone: A Randomized Trial.
Schools
Univ Of Rochester Sch Of Med amp Dentistry
University Of Mi Hosps and Health Ctrs
Procedures Preformed
- Psychiatric Evaluation
- Psychotherapy and Psychophysiological Therapy (incl. Biofeedback)
Conditions Treated
- Adjustment Disorder
- Alcoholism (Alcohol Dependence)
- Anxiety
- Bipolar Disorder
- View All
Doctors Specialties
- Geriatric Psychiatry
- Psychiatry
Accepted Insurances
- Choice Plus POS II
- Amerigroup (Wellpoint)
- Blue Card PPO
- Blue Cross Blue Shield of Illinois PPO
- Blue Care Network PCP Focus Network
- Group Employees PPO
- Blue Cross Accord
- Cofinity PPO
- Commercial Insurance Company
- First Health (Coventry Health Care) PPO
- Golden Rule
- Health Alliance
- Preferred PPO
- Humana
- Medicaid
- Medicare MCR
- MultiPlan PPO
- PHCS Network PPO
- Mutual of Omaha
- Priority PPO
- Tricare
Awards
- CMS Meaningful Use Stage 1 Certification
Education
-
University of Michigan Hospitals and Health Centers -
University of Rochester School of Medicine and Dentistry
Hospital
-
University of Michigan Hospitals and Health Centers
Drug Facts
| NPI NUMBER | 1538245550 | |
| NPPES Provider LastName | KALES | |
| NPPES Provider FirstName | HELEN | |
| NPPES Provider ZIPCode | 481092700 | |
| NPPES Provider State | MI | |
| Specialty Description | Psychiatry | |
| Total Claim Count | 130.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1538245550 |
| Last Name Of The Provider | KALES |
| First Name Of The Provider | HELEN |
| View All |
Similar Doctors
|
|
Dr. Stephen M. Aronson, MD |
|
|
Dr. Dwarakanath G. Rao, MD |
|
|
Dr. David C. Belmonte, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mary C. Blazek, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Lewis P. Krain, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Scott Y. Kim, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Anusha Ranganathan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Susan M. Maixner, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Thomas C. Zelnik, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Daniel E. Gih, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jean-Paul P. Pegeron, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Dimitre H. Dimitrov, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Heba T. Gad, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Aazaz U. Haq, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Arash Javanbakht, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Lindsey Y. Mortenson, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jan Taliga, MD |